Entity

Time filter

Source Type

Sun City Center, United States

Ittmann M.,Baylor College of Medicine | Ittmann M.,Michael bakey Veterans Affairs Medical Center | Huang J.,University of California at Los Angeles | Radaelli E.,University of Milan | And 15 more authors.
Cancer Research | Year: 2013

Animal models, particularly mouse models, play a central role in the study of the etiology, prevention, and treatment of human prostate cancer. While tissue culture models are extremely useful in understanding the biology of prostate cancer, they cannot recapitulate the complex cellular interactions within the tumor microenvironment that play a key role in cancer initiation and progression. The National Cancer Institute (NCI) Mouse Models of Human Cancers Consortium convened a group of human and veterinary pathologists to review the current animal models of prostate cancer and make recommendations about the pathologic analysis of these models. More than 40 different models with 439 samples were reviewed, including genetically engineered mouse models, xenograft, rat, and canine models. Numerous relevant models have been developed over the past 15 years, and each approach has strengths and weaknesses. Analysis of multiple genetically engineered models has shown that reactive stroma formation is present in all the models developing invasive carcinomas. In addition, numerous models with multiple genetic alterations display aggressive phenotypes characterized by sarcomatoid carcinomas and metastases, which is presumably a histologic manifestation of epithelial-mesenchymal transition. The significant progress in development of improved models of prostate cancer has already accelerated our understanding of thecomplex biology of prostate cancer andpromises to enhance developmentof new approaches to prevention, detection, and treatment of this common malignancy. Cancer Res; 73(9); 2718-36. © 2013 AACR. Source

Discover hidden collaborations